Results 231 to 240 of about 92,043 (285)

Biological therapies in paediatric Behçet's disease: results of an international collaborative study by the PRES Vasculitis Working Party. [PDF]

Rheumatology (Oxford)
Akgün Ö, Demirkan FG, Koné-Paut I, Coşkuner T, Çam V, Polat MC, Esen E, Conti EA, Şahin N, Baba Ö, Kılbaş G, Kocamaz NG, Taşkın SN, Rigante D, Jelusic M, Horne A, Öztürk K, Özdel S, Köker O, Yüksel S, Kalyoncu M, Sönmez HE, Filocamo G, Paç Kısaarslan A, Mastrolia MV, Acar BÇ, Benazzouz D, Batu ED, Sözeri B, Saadoun D, Özen S, Aktay Ayaz N.   +31 more
europepmc   +1 more source

Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease. [PDF]

United European Gastroenterol J
Roblin X, Nancey S, Papamichael K, Mechi F, Ouvrier-Buffet J, Charlois AL, Peaucelle AS, Bastide L, Berger AA, Barrau M, Cheifetz AS, Duru G, Paul S.   +12 more
europepmc   +1 more source

Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials. [PDF]

United European Gastroenterol J
Colombel JF, Danese S, Schreiber S, Sands BE, Yarur AJ, Kang A, Kim DH, Lee YN, Hanauer SB.   +8 more
europepmc   +1 more source

Pulmonary Involvement Successfully Treated With Infliximab in a Patient With Pyoderma Gangrenosum and Rheumatoid Arthritis: A Case Report. [PDF]

Respirol Case Rep
Ikeda H, Tachikawa R, Hara S.
europepmc   +1 more source

Anti-TNF Therapies Promote a Proximal-to-Distal Healing Pattern in Moderate-to-Severe Ulcerative Colitis. [PDF]

Inflamm Bowel Dis
Wong ECL, Dulai PS, Marshall JK, Jairath V, Reinisch W, Narula N.   +5 more
europepmc   +1 more source

Real-Life Use of Subcutaneous Biologicals and JAK Inhibitors in IBD Maintenance Therapy: Treatment Continuation, Switching Patterns, and Concomitant Medications. [PDF]

Clin Exp Gastroenterol
Koivusalo M, Jokelainen J, Huhtinen A, Kovac B, Silvola S, Torvinen S, Ylisaukko-Oja T, Arkkila P.   +7 more
europepmc   +1 more source

Modelling the cost effectiveness of TNF-α inhibitors in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry [PDF]

Bansback, N., Brennan, A., Nixon, R.
core